Which pharmaceutical company first launched a successful nationwide subscription model for insulin in the United States, allowing diabetic patients unlimited monthly supplies for a flat fee?

The healthcare industry has been transforming how patients access medications through innovative subscription models. These models have changed how chronic medications are delivered, how patients adhere to treatment plans, and how pharmaceutical companies generate revenue. This poll tests your knowledge about a groundbreaking subscription service that changed medication accessibility for many patients.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

• Eli Lilly with 'Insulin Value Program'
• Novo Nordisk with 'NovoCare Direct'
• Sanofi with 'Insulin ValuScript'
• GlaxoSmithKline with 'DiabetEase Subscription'

Powered by AIPolls.Net — AI-powered real-time polling platform.